Study examined the association of treatment for nodular lymphocyte-predominant Hodgkin lymphoma and family risk for hematological cancers.
Home / Resource Library / Risk of hematological malignancies in the families of patients treated for nodular lymphocyte-predominant Hodgkin lymphoma